HW

Hannah S. White

GT G1 Therapeutics: 7 patents #5 of 31Top 20%
GT Gi Therapeutics: 2 patents #5 of 12Top 45%
RE Restor3D: 2 patents #9 of 17Top 55%
PA Pharmacosmos Holding A/S: 1 patents #8 of 20Top 40%
📍 Durham, NC: #424 of 4,103 inventorsTop 15%
🗺 North Carolina: #4,231 of 45,564 inventorsTop 10%
Overall (All Time): #395,571 of 4,157,543Top 10%
12
Patents All Time

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
12264135 Synthesis of 1,4-diazaspiro[5.5]undecan-3-one Stephen E. Schneider, Thomas Fessard, Sagar Beldar 2025-04-01
12265373 Patient-specific medical devices and additive manufacturing processes for producing the same Cambre Kelly 2025-04-01
12168666 Morphic forms of trilaciclib and methods of manufacture thereof Stephen E. Schneider, Alexander Smith, Jay Copeland Strum, Jaroslaw Mazurek 2024-12-17
12139494 Morphic forms of G1T38 and methods of manufacture thereof Alexander Smith, Patricia Andres, Xufeng Sun, Lei Zhu, Petinka Vlahova 2024-11-12
11960266 Patient-specific medical devices and additive manufacturing processes for producing the same Cambre Kelly 2024-04-16
11708337 Synthesis of 1,4-diazaspiro[5.5]undecan-3-one Stephen E. Schneider, Thomas Fessard, Sagar Beldar 2023-07-25
11629150 Synthesis of N-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines Alexander Smith, Francis Xavier Tavares, Sergiy Krasutsky, Jian-Xie Chen, Roberta L. Dorrow +1 more 2023-04-18
11446295 Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat Rb-positive tumors Jay Copeland Strum, John Emerson Bisi, Patrick Joseph Roberts, Jessica A. Sorrentino 2022-09-20
11261193 Morphic forms of G1T38 and methods of manufacture thereof Alexander Smith, Patricia Andres, Xufeng Sun, Lei Zhu, Petinka Vlahova 2022-03-01
10988479 Morphic forms of trilaciclib and methods of manufacture thereof Stephen E. Schneider, Alexander Smith, Jay Copeland Strum, Jaroslaw Mazurek 2021-04-27
10865210 Synthesis of n-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines Alexander Smith, Francis Xavier Tavares, Sergiy Krasutsky, Jian-Xie Chen, Roberta L. Dorrow +1 more 2020-12-15
10231969 Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat RB-positive tumors Jay Copeland Strum, John Emerson Bisi, Patrick Joseph Roberts, Jessica A. Sorrentino 2019-03-19